KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Total Debt (2019 - 2024)

Historic Total Debt for Hims & Hers Health (HIMS) over the last 6 years, with Q1 2024 value amounting to $7.4 million.

  • Hims & Hers Health's Total Debt changed N/A to $7.4 million in Q1 2024 from the same period last year, while for Mar 2024 it was $7.4 million, marking a year-over-year change of. This contributed to the annual value of $7.4 million for FY2023, which is N/A changed from last year.
  • As of Q1 2024, Hims & Hers Health's Total Debt stood at $7.4 million.
  • In the past 5 years, Hims & Hers Health's Total Debt ranged from a high of $42.8 million in Q4 2021 and a low of $404007.0 during Q3 2020
  • Over the past 5 years, Hims & Hers Health's median Total Debt value was $7.4 million (recorded in 2023), while the average stood at $11.1 million.
  • As far as peak fluctuations go, Hims & Hers Health's Total Debt skyrocketed by 564371.24% in 2021, and later tumbled by 6318.22% in 2023.
  • Quarter analysis of 5 years shows Hims & Hers Health's Total Debt stood at $404007.0 in 2020, then surged by 10502.29% to $42.8 million in 2021, then crashed by 69.72% to $13.0 million in 2022, then crashed by 42.86% to $7.4 million in 2023, then changed by 0.0% to $7.4 million in 2024.
  • Its last three reported values are $7.4 million in Q1 2024, $7.4 million for Q4 2023, and $6.9 million during Q3 2023.